Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11570711 | 0.89 | CYP3A4 (0.50) | CYP3A4SMN1; SMN2ATMGAACRHBP | |
| SCHEMBL27919672 | 0.88 | SMN1; SMN2 (0.50) | CYP3A4SMN1; SMN2TSHRATMLMNA | |
| SCHEMBL16626251 | 0.82 | SMN1; SMN2 (0.55) | CYP3A4SMN1; SMN2TSHRATMLMNA | |
| SCHEMBL3087777 | 0.80 | CYP3A4 (0.91) | CYP3A4SMN1; SMN2TSHRATMLMNA | |
| SCHEMBL29997762 | 0.78 | CYP3A4 (0.54) | CYP3A4SMN1; SMN2TSHRATMLMNA | |
| SCHEMBL6340922 | 0.78 | CES2 (0.58) | SMN1; SMN2TSHRLMNATP53ALDH1A1 | |
| Nitromide SCHEMBL193674 | 0.77 | CYP3A4 (1.00) | CYP3A4SMN1; SMN2TSHRLMNAGAA | |
| Nitromide SCHEMBL17803670 | 0.75 | CYP3A4 (0.96) | CYP3A4SMN1; SMN2TSHRLMNAGAA | |
| SCHEMBL3662651 | 0.74 | CYP3A4 (0.78) | CYP3A4SMN1; SMN2TSHRATMLMNA | |
| SCHEMBL3862638 | 0.73 | ATM (0.50) | CYP3A4SMN1; SMN2ATMGAACRHBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030171561-A1 | Aminocarboxylate ligands having substituted aromatic amide moieties | BRACCO SUISSE SA (CH) | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030171561-A1 | Aminocarboxylate ligands having substituted aromatic amide moieties | ARGLU1, PRMT1, AADAC | CYP3A4 2283/4885SMN1; SMN2 4585/4885TSHR 2437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.